In view of potential anti-HPV activity displayed by berberine through inhibition of constitutively active AP-1 as well as its selective, anti-proliferation and cytotoxic effects coupled with pharmacological safety in human, berberine appears to be a promising therapeutic agent for the treatment of cervical cancers. This evidence concerns the gene FOS and cervical carcinoma.